Genetic Link Possible Cause of Multiple Myeloma
Main Category: Lymphoma / Leukemia / MyelomaAlso Included In: Genetics
Article Date: 07 Mar 2005 - 0:00 PDT
| Patient / Public: | ![]() |
4.83 (6 votes) |
| Healthcare Prof: | ![]() |
3 (2 votes) |
| Article Opinions: | 2 posts |
In this month's Journal of Clinical Oncology, Henry T. Lynch, M.D., hereditary cancer expert, professor of medicine and chairman of preventive medicine at Creighton University Medical Center, calls for further study of a positive genetic link for multiple myeloma and related disorders.
Multiple myeloma is a rare form of cancer exhibited by excessive production of plasma cells in bone marrow. Plasma cells may mass together to form tumors. Multiple myeloma can also be described as multiple tumors.
Dr. Lynch and researchers at eight sites in France, Canada, and the U.S., including colleagues at the University of Nebraska Medical Center, studied 39 families with multiple cases of multiple myeloma and found a possible genetic correlation. In addition, in families with multiple myeloma over several generations, the onset of disease occurred at younger ages in successive generations.
Dr. Lynch recommends further study of familial multiple myeloma. "I propose an international consortium to study familial multiple myeloma, which may provide insights into the causes, control and ultimately the prevention of multiple myeloma and related diseases," said Dr. Lynch.
Research was supported by revenue from Nebraska cigarette taxes awarded to Creighton University and the University of Nebraska Medical Center by the Nebraska Department of Health and Human Services.
Creighton physicians/researchers are significant contributors to national healthcare and educational advancements in the areas of cancer, bacterial resistance, hearing loss, and the conditions that affect bone growth and loss. In the Jesuit Catholic tradition of caring for the whole person - mind, body and spirit - Creighton University Medical Center, for more than a century, has served as a vital source of health care and education in Omaha and the Great Plains.
Creighton University
2500 California Plaza
Omaha, NE 68178
USA
Phone 402-280-2969
Fax 402-280-2549
creighton.edu/PublicRelations.html
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/20805.php>
APA
http://www.medicalnewstoday.com/releases/20805.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
Second Generation Muliple Myeloma Gene
posted by S. M. Johannville on 7 Apr 2006 at 8:27 pmI have the muliple myeloma gene. My father was diagnosed at the age of 69 (he showed signs for two years before diagnosis) and his older sister was diagnosed at age 75 and passed away a few months later.
My opinion is to be tested for this gene if there is someone in your family with this cancer. Although there's no cure the faster treatment begins, a better quality of life may be available.
Pretranplant
posted by santosh on 17 Apr 2007 at 12:57 amPre-requirements for marrow transplantation in multiple myeloma.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




